137080 — Narae NanoTech Balance Sheet
0.000.00%
- KR₩39bn
- KR₩112bn
- KR₩40bn
Annual balance sheet for Narae NanoTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 4,769 | 18,960 | 31,565 | 8,400 | 6,904 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21,305 | 32,742 | 33,857 | 38,344 | 21,740 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 49,036 | 60,523 | 80,732 | 65,213 | 51,080 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 68,031 | 75,151 | 92,567 | 94,578 | 90,691 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 126,947 | 149,522 | 185,445 | 173,053 | 173,432 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 77,719 | 81,823 | 71,950 | 64,216 | 84,542 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 81,027 | 86,948 | 77,476 | 79,499 | 96,987 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 45,921 | 62,574 | 107,969 | 93,554 | 76,445 |
Total Liabilities & Shareholders' Equity | 126,947 | 149,522 | 185,445 | 173,053 | 173,432 |
Total Common Shares Outstanding |